Role of flavonoids in inhibiting triple-negative breast cancer
Frontiers in Pharmacology · 27.08.2024 · 15
DOI: 10.3389/fphar.2024.1411059 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 27.08.2024. Verfasst von Shuai Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Increasing incidences of metastasis or recurrence (or both) in triple-negative breast cancer (TNBC) are a growing concern worldwide, as these events are intricately linked to higher mortality rates in patients with advanced breast cancer. Flavonoids possess several pharmaceutical advantages with multi-level, multi-target, and coordinated intervention abilities for treating TNBC, making them viable for preventing tumor growth and TNBC metastasis. This review focused on the primary mechanisms by which flavonoids from traditional Chinese medicine extracts inhibit TNBC, including apoptosis, blocking of cell cycle and movement, regulation of extracellular matrix degradation, promotion of anti-angiogenesis, inhibition of aerobic glycolysis, and improvement in tumor microenvironment. This review aims to improve the knowledge of flavonoids as a promising pharmacological intervention for patients with TNBC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China.
- The Second Department of Surgery, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, China.
Zitieren
APA
Wang, S., Wang, K., Li, C., Chen, J., & Kong, X. (2024). Role of flavonoids in inhibiting triple-negative breast cancer. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1411059
Vancouver
Wang S, Wang K, Li C, Chen J, Kong X. Role of flavonoids in inhibiting triple-negative breast cancer. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1411059
BibTeX
@article{Wang2024,
author = {Wang, Shuai and Wang, Kuanyu and Li, Cheng and Chen, Jing and Kong, Xiangding},
title = {Role of flavonoids in inhibiting triple-negative breast cancer},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1411059}
}
EUVIMED